The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemi
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2015
Price : $35 *
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 06 Feb 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 21 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 27 Jun 2014 New trial record